NO832700L - Fremgangsmaate for fremstilling av en pyridylalkylnitratforbindelse. - Google Patents
Fremgangsmaate for fremstilling av en pyridylalkylnitratforbindelse.Info
- Publication number
- NO832700L NO832700L NO832700A NO832700A NO832700L NO 832700 L NO832700 L NO 832700L NO 832700 A NO832700 A NO 832700A NO 832700 A NO832700 A NO 832700A NO 832700 L NO832700 L NO 832700L
- Authority
- NO
- Norway
- Prior art keywords
- nitroxymethyl
- lower alkyl
- hydrogen
- produced
- halogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Cardiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8221592 | 1982-07-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO832700L true NO832700L (no) | 1984-02-06 |
Family
ID=10531922
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO832700A NO832700L (no) | 1982-07-26 | 1983-07-25 | Fremgangsmaate for fremstilling av en pyridylalkylnitratforbindelse. |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US4540701A (en:Method) |
| EP (1) | EP0100081B1 (en:Method) |
| JP (1) | JPS5951263A (en:Method) |
| KR (1) | KR900005470B1 (en:Method) |
| AT (1) | ATE40948T1 (en:Method) |
| AU (1) | AU565791B2 (en:Method) |
| CA (1) | CA1216850A (en:Method) |
| DE (1) | DE3379255D1 (en:Method) |
| DK (1) | DK311683A (en:Method) |
| ES (1) | ES8502088A1 (en:Method) |
| FI (1) | FI832490A7 (en:Method) |
| GR (1) | GR78629B (en:Method) |
| HU (1) | HU190497B (en:Method) |
| NO (1) | NO832700L (en:Method) |
| PH (1) | PH18083A (en:Method) |
| SU (1) | SU1189337A3 (en:Method) |
| ZA (1) | ZA835048B (en:Method) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6081166A (ja) * | 1983-10-11 | 1985-05-09 | Fujisawa Pharmaceut Co Ltd | ２−ニトロオキシメチル−６−クロロピリジンのβ−シクロデキストリン包接化合物およびその製造法 |
| JPS6215A (ja) * | 1985-02-26 | 1987-01-06 | Fujisawa Pharmaceut Co Ltd | ２−ニトロオキシメチル−６−クロロピリジンまたはそのβ−シクロデキストリン包接化合物含有持続性製剤 |
| ZA885069B (en) * | 1987-07-24 | 1989-03-29 | Fujisawa Pharmaceutical Co | Sustained-release percutaneous preparations |
| JPH02167279A (ja) * | 1988-09-30 | 1990-06-27 | Taisho Pharmaceut Co Ltd | アポビンカミン酸誘導体 |
| US5047543A (en) * | 1988-11-24 | 1991-09-10 | Taisho Pharmaceutical Co., Ltd. | 1,4-dihydropyridine derivatives |
| CN106318877A (zh) * | 2016-08-29 | 2017-01-11 | 刘翔 | 一种从茯砖茶中分离、纯化冠突散囊菌及其液态培养方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3275642A (en) * | 1962-04-26 | 1966-09-27 | Bard Pharmaceutical Inc | 3-pyridine carbinol nitrate and its preparation |
| US3689494A (en) * | 1971-03-31 | 1972-09-05 | William R J Simpson | N-pyridinealkyl-alkanolamine nitrates |
-
1983
- 1983-07-05 DK DK311683A patent/DK311683A/da not_active Application Discontinuation
- 1983-07-07 FI FI832490A patent/FI832490A7/fi not_active Application Discontinuation
- 1983-07-07 AU AU16635/83A patent/AU565791B2/en not_active Ceased
- 1983-07-11 ZA ZA835048A patent/ZA835048B/xx unknown
- 1983-07-11 GR GR71903A patent/GR78629B/el unknown
- 1983-07-19 JP JP58132645A patent/JPS5951263A/ja active Granted
- 1983-07-20 PH PH29255A patent/PH18083A/en unknown
- 1983-07-20 US US06/515,653 patent/US4540701A/en not_active Expired - Fee Related
- 1983-07-22 ES ES524375A patent/ES8502088A1/es not_active Expired
- 1983-07-23 EP EP83107232A patent/EP0100081B1/en not_active Expired
- 1983-07-23 DE DE8383107232T patent/DE3379255D1/de not_active Expired
- 1983-07-23 AT AT83107232T patent/ATE40948T1/de not_active IP Right Cessation
- 1983-07-25 HU HU832615A patent/HU190497B/hu unknown
- 1983-07-25 NO NO832700A patent/NO832700L/no unknown
- 1983-07-25 SU SU833625197A patent/SU1189337A3/ru active
- 1983-07-26 KR KR1019830003459A patent/KR900005470B1/ko not_active Expired
- 1983-07-26 CA CA000433162A patent/CA1216850A/en not_active Expired
-
1985
- 1985-05-08 US US06/731,893 patent/US4613608A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DK311683D0 (da) | 1983-07-05 |
| CA1216850A (en) | 1987-01-20 |
| EP0100081A3 (en) | 1985-05-02 |
| SU1189337A3 (ru) | 1985-10-30 |
| AU1663583A (en) | 1984-02-02 |
| KR900005470B1 (ko) | 1990-07-30 |
| US4613608A (en) | 1986-09-23 |
| US4540701A (en) | 1985-09-10 |
| AU565791B2 (en) | 1987-10-01 |
| HU190497B (en) | 1986-09-29 |
| ATE40948T1 (de) | 1989-03-15 |
| FI832490A0 (fi) | 1983-07-07 |
| PH18083A (en) | 1985-03-18 |
| FI832490L (fi) | 1984-01-27 |
| DE3379255D1 (en) | 1989-04-06 |
| ES524375A0 (es) | 1984-12-16 |
| JPS5951263A (ja) | 1984-03-24 |
| DK311683A (da) | 1984-01-27 |
| ES8502088A1 (es) | 1984-12-16 |
| FI832490A7 (fi) | 1984-01-27 |
| ZA835048B (en) | 1984-03-28 |
| GR78629B (en:Method) | 1984-09-27 |
| KR840005426A (ko) | 1984-11-12 |
| JPS6350343B2 (en:Method) | 1988-10-07 |
| EP0100081A2 (en) | 1984-02-08 |
| EP0100081B1 (en) | 1989-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002335031B2 (en) | Himbacine analogues as thrombin receptor antagonists | |
| JP2000509408A (ja) | ２−アミノ−６−（２−置換−４−フェノキシ）−置換ピリジン | |
| JPH0395144A (ja) | アミノフェノール誘導体の製造方法 | |
| JP5066638B2 (ja) | ピリジン−１−オキシド誘導体及びその医薬的に有効な化合物へと転換する為の方法 | |
| EP2343296A1 (en) | A process for the purification of paliperidone | |
| KR20000064387A (ko) | 1-벤질-4-((5,6-디메톡시-1-인다논)-2-일)메틸피페리딘을제조하기위한방법및중간체 | |
| EP0161422B1 (en) | Alkanolamine derivatives and platelet aggregation inhibitors containing the same as an active ingredient | |
| CN120737038A (zh) | 三嗪化合物的制造方法 | |
| NO832700L (no) | Fremgangsmaate for fremstilling av en pyridylalkylnitratforbindelse. | |
| JP2023545352A (ja) | 結晶性ｅｄｇ－２受容体アンタゴニストおよび製造方法 | |
| JP3907029B2 (ja) | 環状アミン誘導体を含有する医薬 | |
| JP3053418B2 (ja) | 新規の置換アルキルピペリジンとコレステロール合成阻害剤としてのその用途 | |
| EP2206699A1 (en) | Crystalline form of flupirtine ((2-amino-6-(4-fluoro-benzylamino)-pyridin-3-yl)-carbamic acid ethyl ester) | |
| JP2815150B2 (ja) | 置換されたジベンゾシクロヘプテンイミン | |
| CN1980666A (zh) | 制备阿扎那韦硫酸氢盐的方法和新的形式 | |
| JPS61161278A (ja) | ３‐置換インドールの調製方法 | |
| AU594686B2 (en) | Process for the preparation of 2-halonicergoline derivatives and their acid addition salts and new 2-halonicergolines | |
| SK1582000A3 (en) | CRYSTALLINE 10,10-BIS((2-FLUORO-4-PYRIDINYL)METHYL)-9(10H)-ì (54) -ANTHRACENONE AND AN IMPROVED PROCESS FOR PREPARING THE S | |
| EP2206700A1 (en) | Crystalline form of flupirtine ((2-amino-6-(4-fluoro-benzylamino)-pyridin-3-yl)-carbamic acid ethyl ester) | |
| TAKAYANAGI et al. | Studies on the Chlorinated oz-Santonins. IV.“ | |
| FR2601013A1 (fr) | Nouvelles quinazolinones tetracycliques, leur preparation et leur utilisation comme medicaments | |
| JPS5910358B2 (ja) | 新規エルゴリン誘導体 | |
| EP0298890A2 (en) | New 2-(P-isobutylphenyl)-propionic acid ester and process for the preparation thereof | |
| JPH0373543B2 (en:Method) | ||
| JPS6193161A (ja) | ジヒドロピリジン誘導体の製造法 |